Global Antisense Therapy Market Growth (Status and Outlook) 2025-2031

September 2025 | 112 pages | ID: GC5E311FA289EN
LP Information

Abstracts

According to this study, the global Antisense Therapy market size will reach US$ million by 2031.

United States market for Antisense Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Antisense Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Antisense Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Antisense Therapy players cover Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Inc., Arbutus Biopharma (Tekmira), Isarna Therapeutics, Arrowhead, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Antisense Therapy Industry Forecast” looks at past sales and reviews total world Antisense Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Antisense Therapy sales for 2025 through 2031. With Antisense Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antisense Therapy industry.

This Insight Report provides a comprehensive analysis of the global Antisense Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Antisense Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antisense Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antisense Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antisense Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Antisense Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• RNA Antisense Therapy
• DNA Antisense Therapy

Segmentation by Application:

• Cancer
• Cardiovascular
• HBV
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Alnylam Pharmaceuticals
• Ionis Pharmaceuticals, Inc.
• Arbutus Biopharma (Tekmira)
• Isarna Therapeutics
• Arrowhead
• Dicerna Pharmaceuticals
• Quark Pharmaceuticals
• Benitec Biopharma
• Sylentis
• Gradalis
• Sarepta Therapeutics
• Biogen

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Antisense Therapy Market Size (2020-2031)
  2.1.2 Antisense Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Antisense Therapy by Country/Region (2020, 2024 & 2031)
2.2 Antisense Therapy Segment by Type
  2.2.1 RNA Antisense Therapy
  2.2.2 DNA Antisense Therapy
2.3 Antisense Therapy Market Size by Type
  2.3.1 Antisense Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Antisense Therapy Market Size Market Share by Type (2020-2025)
2.4 Antisense Therapy Segment by Application
  2.4.1 Cancer
  2.4.2 Cardiovascular
  2.4.3 HBV
  2.4.4 Other
2.5 Antisense Therapy Market Size by Application
  2.5.1 Antisense Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Antisense Therapy Market Size Market Share by Application (2020-2025)

3 ANTISENSE THERAPY MARKET SIZE BY PLAYER

3.1 Antisense Therapy Market Size Market Share by Player
  3.1.1 Global Antisense Therapy Revenue by Player (2020-2025)
  3.1.2 Global Antisense Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Antisense Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ANTISENSE THERAPY BY REGION

4.1 Antisense Therapy Market Size by Region (2020-2025)
4.2 Global Antisense Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antisense Therapy Market Size Growth (2020-2025)
4.4 APAC Antisense Therapy Market Size Growth (2020-2025)
4.5 Europe Antisense Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Antisense Therapy Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Antisense Therapy Market Size by Country (2020-2025)
5.2 Americas Antisense Therapy Market Size by Type (2020-2025)
5.3 Americas Antisense Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Antisense Therapy Market Size by Region (2020-2025)
6.2 APAC Antisense Therapy Market Size by Type (2020-2025)
6.3 APAC Antisense Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Antisense Therapy Market Size by Country (2020-2025)
7.2 Europe Antisense Therapy Market Size by Type (2020-2025)
7.3 Europe Antisense Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Antisense Therapy by Region (2020-2025)
8.2 Middle East & Africa Antisense Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Antisense Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ANTISENSE THERAPY MARKET FORECAST

10.1 Global Antisense Therapy Forecast by Region (2026-2031)
  10.1.1 Global Antisense Therapy Forecast by Region (2026-2031)
  10.1.2 Americas Antisense Therapy Forecast
  10.1.3 APAC Antisense Therapy Forecast
  10.1.4 Europe Antisense Therapy Forecast
  10.1.5 Middle East & Africa Antisense Therapy Forecast
10.2 Americas Antisense Therapy Forecast by Country (2026-2031)
  10.2.1 United States Market Antisense Therapy Forecast
  10.2.2 Canada Market Antisense Therapy Forecast
  10.2.3 Mexico Market Antisense Therapy Forecast
  10.2.4 Brazil Market Antisense Therapy Forecast
10.3 APAC Antisense Therapy Forecast by Region (2026-2031)
  10.3.1 China Antisense Therapy Market Forecast
  10.3.2 Japan Market Antisense Therapy Forecast
  10.3.3 Korea Market Antisense Therapy Forecast
  10.3.4 Southeast Asia Market Antisense Therapy Forecast
  10.3.5 India Market Antisense Therapy Forecast
  10.3.6 Australia Market Antisense Therapy Forecast
10.4 Europe Antisense Therapy Forecast by Country (2026-2031)
  10.4.1 Germany Market Antisense Therapy Forecast
  10.4.2 France Market Antisense Therapy Forecast
  10.4.3 UK Market Antisense Therapy Forecast
  10.4.4 Italy Market Antisense Therapy Forecast
  10.4.5 Russia Market Antisense Therapy Forecast
10.5 Middle East & Africa Antisense Therapy Forecast by Region (2026-2031)
  10.5.1 Egypt Market Antisense Therapy Forecast
  10.5.2 South Africa Market Antisense Therapy Forecast
  10.5.3 Israel Market Antisense Therapy Forecast
  10.5.4 Turkey Market Antisense Therapy Forecast
10.6 Global Antisense Therapy Forecast by Type (2026-2031)
10.7 Global Antisense Therapy Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Antisense Therapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 Alnylam Pharmaceuticals
  11.1.1 Alnylam Pharmaceuticals Company Information
  11.1.2 Alnylam Pharmaceuticals Antisense Therapy Product Offered
  11.1.3 Alnylam Pharmaceuticals Antisense Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Alnylam Pharmaceuticals Main Business Overview
  11.1.5 Alnylam Pharmaceuticals Latest Developments
11.2 Ionis Pharmaceuticals, Inc.
  11.2.1 Ionis Pharmaceuticals, Inc. Company Information
  11.2.2 Ionis Pharmaceuticals, Inc. Antisense Therapy Product Offered
  11.2.3 Ionis Pharmaceuticals, Inc. Antisense Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Ionis Pharmaceuticals, Inc. Main Business Overview
  11.2.5 Ionis Pharmaceuticals, Inc. Latest Developments
11.3 Arbutus Biopharma (Tekmira)
  11.3.1 Arbutus Biopharma (Tekmira) Company Information
  11.3.2 Arbutus Biopharma (Tekmira) Antisense Therapy Product Offered
  11.3.3 Arbutus Biopharma (Tekmira) Antisense Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Arbutus Biopharma (Tekmira) Main Business Overview
  11.3.5 Arbutus Biopharma (Tekmira) Latest Developments
11.4 Isarna Therapeutics
  11.4.1 Isarna Therapeutics Company Information
  11.4.2 Isarna Therapeutics Antisense Therapy Product Offered
  11.4.3 Isarna Therapeutics Antisense Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Isarna Therapeutics Main Business Overview
  11.4.5 Isarna Therapeutics Latest Developments
11.5 Arrowhead
  11.5.1 Arrowhead Company Information
  11.5.2 Arrowhead Antisense Therapy Product Offered
  11.5.3 Arrowhead Antisense Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Arrowhead Main Business Overview
  11.5.5 Arrowhead Latest Developments
11.6 Dicerna Pharmaceuticals
  11.6.1 Dicerna Pharmaceuticals Company Information
  11.6.2 Dicerna Pharmaceuticals Antisense Therapy Product Offered
  11.6.3 Dicerna Pharmaceuticals Antisense Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Dicerna Pharmaceuticals Main Business Overview
  11.6.5 Dicerna Pharmaceuticals Latest Developments
11.7 Quark Pharmaceuticals
  11.7.1 Quark Pharmaceuticals Company Information
  11.7.2 Quark Pharmaceuticals Antisense Therapy Product Offered
  11.7.3 Quark Pharmaceuticals Antisense Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Quark Pharmaceuticals Main Business Overview
  11.7.5 Quark Pharmaceuticals Latest Developments
11.8 Benitec Biopharma
  11.8.1 Benitec Biopharma Company Information
  11.8.2 Benitec Biopharma Antisense Therapy Product Offered
  11.8.3 Benitec Biopharma Antisense Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Benitec Biopharma Main Business Overview
  11.8.5 Benitec Biopharma Latest Developments
11.9 Sylentis
  11.9.1 Sylentis Company Information
  11.9.2 Sylentis Antisense Therapy Product Offered
  11.9.3 Sylentis Antisense Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Sylentis Main Business Overview
  11.9.5 Sylentis Latest Developments
11.10 Gradalis
  11.10.1 Gradalis Company Information
  11.10.2 Gradalis Antisense Therapy Product Offered
  11.10.3 Gradalis Antisense Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Gradalis Main Business Overview
  11.10.5 Gradalis Latest Developments
11.11 Sarepta Therapeutics
  11.11.1 Sarepta Therapeutics Company Information
  11.11.2 Sarepta Therapeutics Antisense Therapy Product Offered
  11.11.3 Sarepta Therapeutics Antisense Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Sarepta Therapeutics Main Business Overview
  11.11.5 Sarepta Therapeutics Latest Developments
11.12 Biogen
  11.12.1 Biogen Company Information
  11.12.2 Biogen Antisense Therapy Product Offered
  11.12.3 Biogen Antisense Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Biogen Main Business Overview
  11.12.5 Biogen Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Antisense Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Antisense Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of RNA Antisense Therapy
Table 4. Major Players of DNA Antisense Therapy
Table 5. Antisense Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Antisense Therapy Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Antisense Therapy Market Size Market Share by Type (2020-2025)
Table 8. Antisense Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Antisense Therapy Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Antisense Therapy Market Size Market Share by Application (2020-2025)
Table 11. Global Antisense Therapy Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Antisense Therapy Revenue Market Share by Player (2020-2025)
Table 13. Antisense Therapy Key Players Head office and Products Offered
Table 14. Antisense Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Antisense Therapy Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Antisense Therapy Market Size Market Share by Region (2020-2025)
Table 19. Global Antisense Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Antisense Therapy Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Antisense Therapy Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Antisense Therapy Market Size Market Share by Country (2020-2025)
Table 23. Americas Antisense Therapy Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Antisense Therapy Market Size Market Share by Type (2020-2025)
Table 25. Americas Antisense Therapy Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Antisense Therapy Market Size Market Share by Application (2020-2025)
Table 27. APAC Antisense Therapy Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Antisense Therapy Market Size Market Share by Region (2020-2025)
Table 29. APAC Antisense Therapy Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Antisense Therapy Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Antisense Therapy Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Antisense Therapy Market Size Market Share by Country (2020-2025)
Table 33. Europe Antisense Therapy Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Antisense Therapy Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Antisense Therapy Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Antisense Therapy Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Antisense Therapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Antisense Therapy
Table 39. Key Market Challenges & Risks of Antisense Therapy
Table 40. Key Industry Trends of Antisense Therapy
Table 41. Global Antisense Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Antisense Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Antisense Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Antisense Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Alnylam Pharmaceuticals Details, Company Type, Antisense Therapy Area Served and Its Competitors
Table 46. Alnylam Pharmaceuticals Antisense Therapy Product Offered
Table 47. Alnylam Pharmaceuticals Antisense Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Alnylam Pharmaceuticals Main Business
Table 49. Alnylam Pharmaceuticals Latest Developments
Table 50. Ionis Pharmaceuticals, Inc. Details, Company Type, Antisense Therapy Area Served and Its Competitors
Table 51. Ionis Pharmaceuticals, Inc. Antisense Therapy Product Offered
Table 52. Ionis Pharmaceuticals, Inc. Antisense Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Ionis Pharmaceuticals, Inc. Main Business
Table 54. Ionis Pharmaceuticals, Inc. Latest Developments
Table 55. Arbutus Biopharma (Tekmira) Details, Company Type, Antisense Therapy Area Served and Its Competitors
Table 56. Arbutus Biopharma (Tekmira) Antisense Therapy Product Offered
Table 57. Arbutus Biopharma (Tekmira) Antisense Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Arbutus Biopharma (Tekmira) Main Business
Table 59. Arbutus Biopharma (Tekmira) Latest Developments
Table 60. Isarna Therapeutics Details, Company Type, Antisense Therapy Area Served and Its Competitors
Table 61. Isarna Therapeutics Antisense Therapy Product Offered
Table 62. Isarna Therapeutics Antisense Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Isarna Therapeutics Main Business
Table 64. Isarna Therapeutics Latest Developments
Table 65. Arrowhead Details, Company Type, Antisense Therapy Area Served and Its Competitors
Table 66. Arrowhead Antisense Therapy Product Offered
Table 67. Arrowhead Antisense Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Arrowhead Main Business
Table 69. Arrowhead Latest Developments
Table 70. Dicerna Pharmaceuticals Details, Company Type, Antisense Therapy Area Served and Its Competitors
Table 71. Dicerna Pharmaceuticals Antisense Therapy Product Offered
Table 72. Dicerna Pharmaceuticals Antisense Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Dicerna Pharmaceuticals Main Business
Table 74. Dicerna Pharmaceuticals Latest Developments
Table 75. Quark Pharmaceuticals Details, Company Type, Antisense Therapy Area Served and Its Competitors
Table 76. Quark Pharmaceuticals Antisense Therapy Product Offered
Table 77. Quark Pharmaceuticals Antisense Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Quark Pharmaceuticals Main Business
Table 79. Quark Pharmaceuticals Latest Developments
Table 80. Benitec Biopharma Details, Company Type, Antisense Therapy Area Served and Its Competitors
Table 81. Benitec Biopharma Antisense Therapy Product Offered
Table 82. Benitec Biopharma Antisense Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Benitec Biopharma Main Business
Table 84. Benitec Biopharma Latest Developments
Table 85. Sylentis Details, Company Type, Antisense Therapy Area Served and Its Competitors
Table 86. Sylentis Antisense Therapy Product Offered
Table 87. Sylentis Antisense Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Sylentis Main Business
Table 89. Sylentis Latest Developments
Table 90. Gradalis Details, Company Type, Antisense Therapy Area Served and Its Competitors
Table 91. Gradalis Antisense Therapy Product Offered
Table 92. Gradalis Antisense Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Gradalis Main Business
Table 94. Gradalis Latest Developments
Table 95. Sarepta Therapeutics Details, Company Type, Antisense Therapy Area Served and Its Competitors
Table 96. Sarepta Therapeutics Antisense Therapy Product Offered
Table 97. Sarepta Therapeutics Antisense Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Sarepta Therapeutics Main Business
Table 99. Sarepta Therapeutics Latest Developments
Table 100. Biogen Details, Company Type, Antisense Therapy Area Served and Its Competitors
Table 101. Biogen Antisense Therapy Product Offered
Table 102. Biogen Antisense Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Biogen Main Business
Table 104. Biogen Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Antisense Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antisense Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Antisense Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Antisense Therapy Sales Market Share by Country/Region (2024)
Figure 8. Antisense Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Antisense Therapy Market Size Market Share by Type in 2024
Figure 10. Antisense Therapy in Cancer
Figure 11. Global Antisense Therapy Market: Cancer (2020-2025) & ($ millions)
Figure 12. Antisense Therapy in Cardiovascular
Figure 13. Global Antisense Therapy Market: Cardiovascular (2020-2025) & ($ millions)
Figure 14. Antisense Therapy in HBV
Figure 15. Global Antisense Therapy Market: HBV (2020-2025) & ($ millions)
Figure 16. Antisense Therapy in Other
Figure 17. Global Antisense Therapy Market: Other (2020-2025) & ($ millions)
Figure 18. Global Antisense Therapy Market Size Market Share by Application in 2024
Figure 19. Global Antisense Therapy Revenue Market Share by Player in 2024
Figure 20. Global Antisense Therapy Market Size Market Share by Region (2020-2025)
Figure 21. Americas Antisense Therapy Market Size 2020-2025 ($ millions)
Figure 22. APAC Antisense Therapy Market Size 2020-2025 ($ millions)
Figure 23. Europe Antisense Therapy Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Antisense Therapy Market Size 2020-2025 ($ millions)
Figure 25. Americas Antisense Therapy Value Market Share by Country in 2024
Figure 26. United States Antisense Therapy Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Antisense Therapy Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Antisense Therapy Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Antisense Therapy Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Antisense Therapy Market Size Market Share by Region in 2024
Figure 31. APAC Antisense Therapy Market Size Market Share by Type (2020-2025)
Figure 32. APAC Antisense Therapy Market Size Market Share by Application (2020-2025)
Figure 33. China Antisense Therapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Antisense Therapy Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Antisense Therapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Antisense Therapy Market Size Growth 2020-2025 ($ millions)
Figure 37. India Antisense Therapy Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Antisense Therapy Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Antisense Therapy Market Size Market Share by Country in 2024
Figure 40. Europe Antisense Therapy Market Size Market Share by Type (2020-2025)
Figure 41. Europe Antisense Therapy Market Size Market Share by Application (2020-2025)
Figure 42. Germany Antisense Therapy Market Size Growth 2020-2025 ($ millions)
Figure 43. France Antisense Therapy Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Antisense Therapy Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Antisense Therapy Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Antisense Therapy Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Antisense Therapy Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Antisense Therapy Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Antisense Therapy Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Antisense Therapy Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Antisense Therapy Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Antisense Therapy Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Antisense Therapy Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Antisense Therapy Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 56. APAC Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 57. Europe Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 59. United States Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 60. Canada Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 61. Mexico Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 62. Brazil Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 63. China Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 64. Japan Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 65. Korea Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 67. India Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 68. Australia Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 69. Germany Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 70. France Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 71. UK Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 72. Italy Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 73. Russia Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 74. Egypt Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 75. South Africa Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 76. Israel Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 77. Turkey Antisense Therapy Market Size 2026-2031 ($ millions)
Figure 78. Global Antisense Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Antisense Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Antisense Therapy Market Size 2026-2031 ($ millions)